Your browser doesn't support javascript.
loading
Predicting Survival for Chimeric Antigen Receptor T-Cell Therapy: A Validation of Survival Models Using Follow-Up Data From ZUMA-1.
Vadgama, Sachin; Mann, Jess; Bashir, Zahid; Spooner, Clare; Collins, Graham P; Bullement, Ash.
Afiliação
  • Vadgama S; Kite, a Gilead Company, Stockley Park, Uxbridge, England, UK; Department of Medicine, University College London, England, UK. Electronic address: sachin.vadgama@gilead.com.
  • Mann J; Delta Hat Ltd, Nottingham, England, UK.
  • Bashir Z; Kite, a Gilead Company, Stockley Park, Uxbridge, England, UK.
  • Spooner C; Kite, a Gilead Company, Stockley Park, Uxbridge, England, UK.
  • Collins GP; Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, England, UK.
  • Bullement A; Delta Hat Ltd, Nottingham, England, UK; School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
Value Health ; 25(6): 1010-1017, 2022 06.
Article em En | MEDLINE | ID: mdl-35667774
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article